flow trial semaglutide kidney outcomes hazard ratio 0.76 nejm 2024 Effects of on Heart Failure in Diabetes and Chronic Disease in the Contrary to popular belief: GLP-1
Description
Avoid applying topical treatments immediately before your next injection to minimise skin irritation
Originally developed to treat Type 2 diabetes, those GLP-1 medications help regulate appetite and blood sugar, leading many patients to experience significant weight loss
FDA approved the first new class of weight-loss medications after almost a decade, called Semaglutide or GLP-1
only minor issue was the tracking info took a day to update after shipping
Neurol Clin Pract 2021;11:e504-7
